Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|March 1, 1989
Is the published literature a reliable guide for deciding between alternative treatments for patients with early cervical cancer?P Zola, T Volpe, G Castelli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1989
Complications of uterine cervix carcinoma treatments: the problem of a uniform classificationP Sismondi, G Sinistrero, P Zola, et al.
Blood|October 1, 1985
Binding characteristics of anti-Rh0(D) antibodies to Rh0(D)-positive and Du red cellsN A Cunningham, A P Zola, H L Hui, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|March 3, 2001
[Assessment of reticulocyte hemoglobin content as a guide for iron supplementation in hemodialyzed patients]G M Bosticardo, F Arnoletti, D Dapiran, et al.
International Journal of Oncology|May 11, 2011
Weekly Cisplatin induction chemotherapy in high-risk cervical-cancer patients with bulky tumor - a phase-ii studyD Katsaros, P Zola, G Sinistrero, et al.
European Journal of Gynaecological Oncology|September 23, 2015
CO2 laser vaporization for the treatment of vaginal intraepithelial neoplasia: effectiveness and predictive factors for recurrenceE Piovano, C Macchi, L Attamante, et al.
British Journal of Cancer|July 27, 2006
Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trialR Maggi, A Lissoni, F Spina, et al.
International Journal of Oncology|May 17, 2011
Avm (adriamycin, vinblastine, methotrexate) neoadjuvant chemotherapy in advanced or inflammatory carcinoma of the breastP Zola, G Schnapper, D Katsaros, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 1, 1997
Serum CA125 assay at the time of relapse has no prognostic relevance in patients undergoing chemotherapy for recurrent ovarian cancer: a multicenter Italian studyA Gadducci, F Landoni, T Maggino, et al.
Cancer|March 15, 1995
Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinomaM A Levesque, D Katsaros, H Yu, et al.
Pageof 8